Author Correction: Universal toxin-based selection for precise genome engineering in human cells
Nat Commun
.
2021 May 10;12(1):2832.
doi: 10.1038/s41467-021-23345-z.
Authors
Songyuan Li
1
,
Nina Akrap
#
2
,
Silvia Cerboni
#
3
,
Michelle J Porritt
2
,
Sandra Wimberger
2
4
,
Anders Lundin
2
,
Carl Möller
2
,
Mike Firth
5
,
Euan Gordon
6
,
Bojana Lazovic
2
7
,
Aleksandra Sieńska
2
,
Luna Simona Pane
2
,
Matthew A Coelho
8
,
Giovanni Ciotta
9
,
Giovanni Pellegrini
10
,
Marcella Sini
10
,
Xiufeng Xu
11
,
Suman Mitra
12
,
Mohammad Bohlooly-Y
2
,
Benjamin J M Taylor
9
,
Grzegorz Sienski
13
,
Marcello Maresca
14
Affiliations
1
Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. songyuan.li@astrazeneca.com.
2
Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
3
Translational Science and Experimental Medicine, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
4
Department of Chemistry & Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
5
R&D Data Infrastructure & Tools, AstraZeneca, Cambridge, UK.
6
Discovery Biology SWE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
7
Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
8
Wellcome Sanger Institute, Cambridge, UK.
9
Discovery Biology UK, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
10
CVRM pathology, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
11
Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden.
12
Inserm UMR1277 CNRS UMR9020 - CANTHER, Institut pour la Recherche sur le Cancer de Lille, Lille, France.
13
Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. grzegorz.sienski@astrazeneca.com.
14
Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Marcello.Maresca@astrazeneca.com.
#
Contributed equally.
PMID:
33972550
PMCID:
PMC8110559
DOI:
10.1038/s41467-021-23345-z
No abstract available
Publication types
Published Erratum